Doctor Debora Sa
Hospital Dr. Nelio Mendonca, Funchal (Portugal)
GJA4 gene inhibition may represent a potential target for novel antithrombotic therapies
Event: ESC Congress 2024
Topic: Cardiovascular Risk Assessment
Session: Biomarkers to assess cardiovascular risk
Diabetes Mellitus influence in Lipoprotein(a) gene expression and association to coronary artery disease
Event: ESC Congress 2024
Topic: Pathophysiology
Session: Diabetes: a risk factor in heart disease
Does the LPA genotype have a role in coronary artery disease risk beyond Lp(a) values?
Event: ESC Congress 2024
Topic: Biomarkers
Session: Lp(a) and apoproteins as risk factors
Is the HNF4A gene variant paradoxically associated with better prognostic in CAD patients?
Event: ESC Congress 2024
Topic: Pathophysiology and Mechanisms
Session: Cardiovascular disease: genetic determinants and molecular phenotyping
Progress in understanding the genetic underpinning of coronary artery disease: from genotype to phenotype
Event: ESC Congress 2024
Topic: Scores
Session: Genetic predisposition and heart disease
ZNF259 rs964184 genetic variant is associated with metabolic syndrome in a Portuguese population
Event: ESC Congress 2023
Topic: Metabolic Syndrome, Insulin, Insulin Resistance
Session: Diabetes and the heart
TCF21 gene and cardiovascular events in a coronary population
Event: ESC Congress 2023
Topic: Biomarkers
Session: Epigenetics and cardiovascular diseases: bench to bedside
A better understanding of coronary artery disease molecular biology through an intermediate phenotype
Event: ESC Congress 2023
Topic: Genetics, Epigenetics, ncRNA
Session: Vascular dysfunction
Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and impaired glucose metabolism
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Coronary artery disease - Epidemiology, prognosis, outcome 5
Genetic information or coronary artery calcium score? What is more helpful in today's clinical practice?
Event: ESC Congress 2022
Topic: Scores
Session: Cardiovascular risk assessment - Scores 2
